Roth Capital Starts Nektar Therapeutics (NKTR) at Buy
Tweet Send to a FriendGet Alerts NKTR Hot Sheet
Price: $9.74 -0.51%
Rating Summary:
3 Buy, 1 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 36 | New: 12
Rating Summary:
3 Buy, 1 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 36 | New: 12
Trade NKTR Now!
Roth Capital initiates coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy. PT $10.00.
For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.
Shares of Nektar Therapeutics closed at $6.97 yesterday, with a 52 week range of $4.07-$9.71.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.
Shares of Nektar Therapeutics closed at $6.97 yesterday, with a 52 week range of $4.07-$9.71.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: BTIG Starts ING U.S (VOYA) at Buy, Shares 'Significantly Undervalued'
- BTIG Starts Ambac Financial (AMBC) at Buy, Interesting Play with 'Optionality'
- BofA/Merrill Lynch Starts Franklin Street Properties (FSP) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
